Apellis Pharmaceuticals Inc Virtual Investorm Meeting - Pegcetacoplan: Advancing the First Potential Treatment for Geographic Atrophy (GA) Transcript - Thomson StreetEvents

Apellis Pharmaceuticals Inc Virtual Investorm Meeting - Pegcetacoplan: Advancing the First Potential Treatment for Geographic Atrophy (GA) Transcript

Apellis Pharmaceuticals Inc Virtual Investorm Meeting - Pegcetacoplan: Advancing the First Potential Treatment for Geographic Atrophy (GA) Transcript - Thomson StreetEvents
Apellis Pharmaceuticals Inc Virtual Investorm Meeting - Pegcetacoplan: Advancing the First Potential Treatment for Geographic Atrophy (GA) Transcript
Published Jan 28, 2021
Published Jan 28, 2021
Price US$ 54.00  |  Buy this Report Now

About This Report

  
Abstract:

Edited Transcript of APLS.OQ corporate analyst meeting

  
Report Type:

Transcript

Source:
Thomson StreetEvents
Company:
Apellis Pharmaceuticals Inc
Ticker
APLS.OQ
Time
3:00pm GMT
Format:
PDF Adobe Acrobat
Buy Now

The following is excerpted from the question-and-answer section of the transcript.

(Questions from industry analysts are provided in full, but answers are omitted - download the transcript to see the full question-and-answer session)

Question: Matthew W. Luchini - BMO Capital Markets Equity Research - Analyst : Thank you for the nice presentation. For the physicians on the panel, particularly those that don't have really any experience with pegcetacoplan, would love to just get your sense on how, when the drug becomes available, you plan to roll it out in your patient population. Are you anticipating sort of broad use among patients you've already identified? Do you want to get a little bit of firsthand experience in a few patients before trying it out more broadly? I'd just like to understand how you're thinking about that. And then quickly for the company, can you just remind us quickly your -- where you stand from manufacturing, manufacturing capacity, specifically as it relates to GA?

Table Of Contents

Apellis Pharmaceuticals Inc at Bank of America NAPA Healthcare Conference Transcript – 2021-06-16 – US$ 54.00 – Edited Transcript of APLS.OQ presentation 16-Jun-21 8:30pm GMT

Apellis Pharmaceuticals Inc at Goldman Sachs Global Healthcare Conference (Virtual) Transcript – 2021-06-10 – US$ 54.00 – Edited Transcript of APLS.OQ presentation 10-Jun-21 12:00pm GMT

Apellis Pharmaceuticals Inc EMPAVELI FDA Approval Call Transcript – 2021-05-17 – US$ 54.00 – Edited Transcript of APLS.OQ conference call or presentation 17-May-21 12:00pm GMT

Apellis Pharmaceuticals Inc Q1 2021 Earnings Call Transcript – 2021-04-28 – US$ 54.00 – Edited Transcript of APLS.OQ earnings conference call or presentation 28-Apr-21 8:30pm GMT

Apellis Pharmaceuticals Inc Q4 2020 Earnings Call Transcript – 2021-02-25 – US$ 54.00 – Edited Transcript of APLS.OQ earnings conference call or presentation 25-Feb-21 9:30pm GMT

Apellis Pharmaceuticals Inc at JPMorgan Healthcare Conference (Virtual) Transcript – 2021-01-12 – US$ 54.00 – Edited Transcript of APLS.OQ presentation 12-Jan-21 3:50pm GMT

Apellis Pharmaceuticals Inc Sobi Strategic Collaboration Conference Call Transcript – 2020-10-27 – US$ 54.00 – Edited Transcript of APLS.OQ conference call or presentation 27-Oct-20 12:30pm GMT

Apellis Pharmaceuticals Inc at Citi BioPharma Conference (Virtual) - Fireside Chat Transcript – 2020-09-10 – US$ 54.00 – Edited Transcript of APLS.OQ presentation 10-Sep-20 7:20pm GMT

More from Thomson StreetEvents

Thomson StreetEvents—Thomson StreetEvents is a leading provider of Web-based solutions for the investment community, offering services that transform the way companies communicate and meet disclosure requirements while assisting investors in managing and leveraging this information. Thomson StreetEvents service offers institutional investors a one-stop solution for managing corporate disclosure information by aggregating conference calls, webcasts, transcripts, call summaries, and other financial information into a time-saving, efficiency tool.
Purchase Thomson StreetEvents' Transcripts (verbatim reports) and Briefs (call summaries) of earnings, guidance, M&A and other corporate calls directly through Alacra. Discounted prices apply to reports produced over two weeks ago.

About the Author


Cite this Report

  
MLA:
Thomson StreetEvents. "Apellis Pharmaceuticals Inc Virtual Investorm Meeting - Pegcetacoplan: Advancing the First Potential Treatment for Geographic Atrophy (GA) Transcript" Jan 28, 2021. Alacra Store. May 04, 2025. <http://www.alacrastore.com/thomson-streetevents-transcripts/Apellis-Pharmaceuticals-Inc-Virtual-Investorm-Meeting-Pegcetacoplan-Advancing-the-First-Potential-Treatment-for-Geographic-Atrophy-GA-T13600676>
  
APA:
Thomson StreetEvents. (2021). Apellis Pharmaceuticals Inc Virtual Investorm Meeting - Pegcetacoplan: Advancing the First Potential Treatment for Geographic Atrophy (GA) Transcript Jan 28, 2021. New York, NY: Alacra Store. Retrieved May 04, 2025 from <http://www.alacrastore.com/thomson-streetevents-transcripts/Apellis-Pharmaceuticals-Inc-Virtual-Investorm-Meeting-Pegcetacoplan-Advancing-the-First-Potential-Treatment-for-Geographic-Atrophy-GA-T13600676>
  
US$ 54.00
$  £  €
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our Credit Research from one place.